Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1980 1
1983 1
1985 1
1986 5
1987 3
1988 1
1989 5
1990 3
1991 3
1992 3
1993 2
1994 1
1995 5
1996 2
1997 3
1998 1
1999 3
2000 3
2001 4
2002 3
2003 3
2004 2
2005 7
2006 7
2007 6
2008 2
2009 3
2011 3
2013 1
2014 1
2015 1
2017 1
2018 2
2021 6
2022 3
2023 4
2024 3
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
The therapeutic potential of resolvins in pulmonary diseases.
Centanni D, Henricks PAJ, Engels F. Centanni D, et al. Among authors: engels f. Eur J Pharmacol. 2023 Nov 5;958:176047. doi: 10.1016/j.ejphar.2023.176047. Epub 2023 Sep 22. Eur J Pharmacol. 2023. PMID: 37742814 Free article. Review.
Methotrexate toxicity and glucarpidase: A call for dose optimization.
Koppen A, Sikma MA, Engels FK, Heerma van Voss MR, Chamuleau MED, Bartelink IH, Dijkman MA. Koppen A, et al. Among authors: engels fk. Br J Clin Pharmacol. 2025 May;91(5):1289-1292. doi: 10.1002/bcp.70044. Epub 2025 Mar 12. Br J Clin Pharmacol. 2025. PMID: 40070262 No abstract available.
Mechanisms of allergy and asthma.
Nauta AJ, Engels F, Knippels LM, Garssen J, Nijkamp FP, Redegeld FA. Nauta AJ, et al. Among authors: engels f. Eur J Pharmacol. 2008 May 13;585(2-3):354-60. doi: 10.1016/j.ejphar.2008.02.094. Epub 2008 Mar 18. Eur J Pharmacol. 2008. PMID: 18410921 Review.
IGHG Recommendations for Anthracycline and Anthraquinone Cardiac Dysfunction Equivalence Ratios After Childhood Cancer: JACC: CardioOncology Expert Panel.
Kouwenberg TW, van Dalen EC, Mulder RL, Armenian S, Feijen EAM, Chow EJ, Kosmidis H, Vormoor-Bürger BJ, Kiyotani C, Nathan PC, Kapusta L, Grotenhuis HB, Engels FK, Teske AJ, Tragiannidis A, Slieker MG, Ozono S, Nohria A, Sláma T, Skinner R, Hudson MM, Kremer LCM, Ehrhardt MJ, Mavinkurve-Groothuis AMC. Kouwenberg TW, et al. Among authors: engels fk. JACC CardioOncol. 2025 Oct;7(6):683-690. doi: 10.1016/j.jaccao.2025.05.009. Epub 2025 Jun 20. JACC CardioOncol. 2025. PMID: 40542813 Free article. Review.
Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
de Baat EC, van Dalen EC, Mulder RL, Hudson MM, Ehrhardt MJ, Engels FK, Feijen EAM, Grotenhuis HB, Leerink JM, Kapusta L, Kaspers GJL, Merkx R, Mertens L, Skinner R, Tissing WJE, de Vathaire F, Nathan PC, Kremer LCM, Mavinkurve-Groothuis AMC, Armenian S. de Baat EC, et al. Among authors: engels fk. Lancet Child Adolesc Health. 2022 Dec;6(12):885-894. doi: 10.1016/S2352-4642(22)00239-5. Epub 2022 Sep 27. Lancet Child Adolesc Health. 2022. PMID: 36174614 Review.
Drug-drug interactions in pediatric oncology patients.
Balk TE, van der Sijs IH, van Gelder T, Janssen JJB, van der Sluis IM, van Leeuwen RWF, Engels FK. Balk TE, et al. Among authors: engels fk. Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26410. Epub 2017 Feb 16. Pediatr Blood Cancer. 2017. PMID: 28205376
110 results